Taclonex Scalp
Product Images NDC 54868-6091

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Taclonex Scalp (NDC 54868-6091). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

3 Scalp Images (3 Scalp Images)

3 Scalp Images (3 Scalp Images)
Taclonex Scalp® Topical Suspension can be applied directly to affected areas of the scalp without the need to wash hair beforehand. It is recommended to gently rub the suspension into the scalp using fingertips. Taclonex Scalp® Topical Suspension is used to treat psoriasis.*
FDA Label Image

Image Of Betamethasone Dipropionate Chemical Structure (Betamethasone Dipropionate Chemical Structure)

FDA Label Image

Image Of Calcipotriene Hydrate Chemical Structure (Calcipotriene Hydrate Chemical Structure)

FDA Label Image

Image Of Leo (Leo)

FDA Label Image

Image Of Package Label (Package Label)

Image Of Package Label (Package Label)
This is a medication called TACLOKEX, distributed by PHYSICIANS TOTAL CARE and packaged under NDC number 54868-6091-0 as a scalp suspension. The information "Ty 40, Wi 0" is unclear and its relevance is unknown. The last line "£0310600000" appears to be a code or identifier but its purpose is not specified.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.